loadpatents
name:-0.012305974960327
name:-0.012314081192017
name:-0.0032980442047119
SMITH; LEONARD A. Patent Filings

SMITH; LEONARD A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SMITH; LEONARD A..The latest application filed is for "small molecule inhibitors of botulinum neurotoxins".

Company Profile
3.10.11
  • SMITH; LEONARD A. - FORT DETRICK MD
  • Smith; Leonard A - Clarksburg MD
  • Smith; Leonard A. - Clarksburg MD
  • Smith; Leonard A. - Streamwood IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Small Molecule Inhibitors Of Botulinum Neurotoxins
App 20190256471 - ROXAS-DUNCAN; VIRGINIA I. ;   et al.
2019-08-22
Small molecule inhibitors of botulinum neurotoxins
Grant 10,301,265 - Roxas-Duncan , et al.
2019-05-28
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
App 20130345398 - Smith; Leonard A ;   et al.
2013-12-26
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
Grant 8,153,397 - Smith , et al. April 10, 2
2012-04-10
Small Molecule Inhibitors Of Botulinum Neurotoxins
App 20110294848 - Roxas-Duncan; Virginia I. ;   et al.
2011-12-01
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
App 20100273211 - Smith; Leonard A. ;   et al.
2010-10-28
Recombinant vaccine against botulinum neurotoxin
Grant 7,786,285 - Smith , et al. August 31, 2
2010-08-31
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
Grant 7,227,010 - Smith June 5, 2
2007-06-05
Recombinant Light Chains Of Botulinum Neurotoxins And Light Chain Fusion Proteins For Use In Research And Clinical Therapy
App 20070104737 - Smith; Leonard A.
2007-05-10
Recombinant vaccine against botulinum neurotoxin
Grant 7,214,787 - Smith , et al. May 8, 2
2007-05-08
Recombinant vaccine against botulinum neurotoxin
App 20070037257 - Smith; Leonard A. ;   et al.
2007-02-15
Recombinant vaccine against botulinum neurotoxin
Grant 7,081,529 - Smith , et al. July 25, 2
2006-07-25
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
App 20060141572 - Smith; Leonard A. ;   et al.
2006-06-29
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
Grant 7,037,680 - Smith , et al. May 2, 2
2006-05-02
Compositions comprising bioactive peptides prepared without formation of native disulfide bonds
Grant 6,670,148 - Mundschenk , et al. December 30, 2
2003-12-30
Polypeptide compositions and methods
App 20030215437 - Mundschenk, David D. ;   et al.
2003-11-20
Recombinant vaccine against botulinum neurotoxin
App 20030009025 - Smith, Leonard A. ;   et al.
2003-01-09
Polypeptide Compositions And Methods
App 20020068317 - MUNDSCHENK, DAVID D. ;   et al.
2002-06-06
Enclosed plug-in fuse assembly
Grant 4,344,060 - Ciesemier , et al. August 10, 1
1982-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed